Page 108 - 《中国药房》2024年13期
P. 108

mononuclear  cells  in  patients  with  no-option  limb  ische-   Third Military Medical University (SWH2005A109)[J]. J
               mia:the  randomized,double-blind,placebo-controlled      Med Coll PLA,2008,23(2):106-115.
               rejuvenating endothelial progenitor cells via transcutaneous   [26]  HUANG P P,YANG X F,LI S Z,et al. Randomised com‐
               intra-arterial supplementation (JUVENTAS) trial[J]. Cir‐  parison  of  G-CSF-mobilized  peripheral  blood  mono‐
               culation,2015,131(10):851-860.                      nuclear  cells  versus  bone  marrow-mononuclear  cells  for
          [18]  LI  M,ZHOU  H,JIN  X,et  al. Autologous  bone  marrow   the  treatment  of  patients  with  lower  limb  arteriosclerosis
               mononuclear  cells  transplant  in  patients  with  critical  leg   obliterans[J]. Thromb Haemost,2007,98(6):1335-1342.
               ischemia:preliminary  clinical  results[J].  Exp  Clin Trans‐  [27]  ARAI M,YU M S,NAGAI H,et al. Granulocyte colony-
               plant,2013,11(5):435-439.                           stimulating factor:a noninvasive regeneration therapy for
          [19]  GUPTA  P  K,CHULLIKANA  A,PARAKH  R,et  al.  A     treating atherosclerotic peripheral artery disease[J]. Circ J,
               double  blind  randomized  placebo  controlled  phase  Ⅰ/Ⅱ   2006,70(9):1093-1098.
               study assessing the safety and efficacy of allogeneic bone   [28]  HUANG P P,LI S Z,HAN M Z,et al. Autologous trans‐
               marrow  derived  mesenchymal  stem  cell  in  critical  limb   plantation  of  granulocyte  colony-stimulating  factor-
               ischemia[J]. J Transl Med,2013,11:143.              mobilized  peripheral  blood  mononuclear  cells  improves
          [20]  OZTURK A,KUCUKARDALI Y,TANGI F,et al. Thera‐       critical limb ischemia in diabetes[J]. Diabetes Care,2005,
               peutical  potential  of  autologous  peripheral  blood  mono‐  28(9):2155-2160.
               nuclear cell transplantation in patients with type 2 diabetic   [29]  TATEISHI-YUYAMA  E,MATSUBARA  H,MUROHARA
               critical limb ischemia[J]. J Diabetes Complications,2012,  T,et  al. Therapeutic  angiogenesis  for  patients  with  limb
               26(1):29-33.                                        ischemia  by  autologous  transplantation  of  bone-marrow
          [21]  LOSORDO D W,KIBBE M R,MENDELSOHN F,et al.          cells:a  pilot  study  and  a  randomised  controlled  trial[J].
               A randomized,controlled pilot study of autologous CD34    Lancet,2002,360(9331):427-435.
                                                         +
               cell therapy for critical limb ischemia[J]. Circ Cardiovasc   [30]  MATSUI K,MURAKAMI Y,YOSHIOKA T,et al. Thera‐
               Interv,2012,5(6):821-830.                           peutic angiogenesis by transplantation of autologous bone
          [22]  WALTER D H,KRANKENBERG H,BALZER J O,et al.         marrow  and  peripheral  blood  mononuclear  cells  in  pa‐
               Intraarterial  administration  of  bone  marrow  mononuclear   tients  with  peripheral  arterial  disease[J].  Int  J  Angiol,
               cells in patients with critical limb ischemia:a randomized-  2003,12(3):155-161.
               start,placebo-controlled  pilot  trial (PROVASA)[J].  Circ   [31]  ZHOU B,BI Y Y,HAN Z B,et al. G-CSF-mobilized pe‐
               Cardiovasc Interv,2011,4(1):26-37.                  ripheral  blood  mononuclear  cells  from  diabetic  patients
          [23]  LU  D  B,CHEN  B,LIANG  Z  W,et  al.  Comparison  of   augment neovascularization in ischemic limbs but with im‐
               bone marrow mesenchymal stem cells with bone marrow-  paired capability[J]. J Thromb Haemost,2006,4(5):993-
               derived mononuclear cells for treatment of diabetic criti‐  1002.
               cal  limb  ischemia  and  foot  ulcer:a  double-blind,rando-   [32]  DE ANGELIS B,GENTILE P,ORLANDI F,et al. Limb
               mized,controlled trial[J]. Diabetes Res Clin Pract,2011,  rescue:a  new  autologous-peripheral  blood  mononuclear
               92(1):26-36.                                        cells  technology  in  critical  limb  ischemia  and  chronic
          [24]  DASH  N  R,DASH  S  N,ROUTRAY  P,et  al. Targeting   ulcers[J].  Tissue  Eng  Part  C  Methods,2015,21(5):
               nonhealing ulcers of lower extremity in human through au‐  423-435.
               tologous  bone  marrow-derived  mesenchymal  stem  cells  [33]  ISHIDA A,OHYA Y,SAKUDA H,et al. Autologous pe‐
               [J]. Rejuvenation Res,2009,12(5):359-366.           ripheral blood mononuclear cell implantation for patients
          [25]  LU  D  B,JIANG  Y  Z,LIANG  Z  W,et  al.  Autologous   with peripheral arterial disease improves limb ischemia[J].
               transplantation  of  bone  marrow  mesenchymal  stem  cells   Circ J,2005,69(10):1260-1265.
               on  diabetic  patients  with  lower  limb  ischemia  supported   (收稿日期:2023-12-16  修回日期:2024-06-04)
               by  the  clinical  research  fund  of  Southwest  Hospital  at                     (编辑:刘明伟)










          · 1642 ·    China Pharmacy  2024 Vol. 35  No. 13                            中国药房  2024年第35卷第13期
   103   104   105   106   107   108   109   110   111   112   113